Study Data
| Project uploaded by: | Upasna |
| Project ID: | IMP_100033 |
| Title: | Characterizing Metabolic Dysregulation in Early-Stage Chronic Kidney Disease for Diagnostic Insight |
| Project Description: | Chronic kidney disease (CKD) is a progressive condition that can be difficult to diagnose in its early stages, as conventional diagnostic methods such as serum creatinine and albumin assessments are often insufficient. Early-stage CKD (Stages G1-G3), defined by a glomerular filtration rate (GFR) of ≥30 mL/min/1.73 m², typically reflects normal to moderately reduced kidney function, often without overt symptoms. This study aims to address the gap in early CKD diagnosis by identifying metabolic alterations and potential biomarkers that could enable earlier detection and personalized treatment strategies. To investigate specific metabolic changes associated with early CKD, we performed a comprehensive metabolomic analysis of 115 human serum samples, including 24 healthy controls and 91 patients with early-stage CKD, using 1H nuclear magnetic resonance (NMR). Data preprocessing and statistical analyses, including principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), orthogonal PLS-DA (OPLS-DA), ANOVA, and Student's t-test, were conducted using MetaboAnalyst 6.0. Random forest modeling demonstrated strong differentiation between CKD stages. The diagnostic potential of the differentially regulated metabolites was assessed using Receiver Operating Characteristic (ROC) analysis, and metabolic pathway enrichment was conducted using the KEGG database. We identified significant alterations in ten metabolites across CKD stages: myo-inositol, glycerol, pyruvate, carnitine, phenylalanine, tyrosine, histidine, TMAO, 2-hydroxyisobutyrate, and 3-hydroxyisobutyrate (p < 0.05, VIP > 1). ROC analysis revealed area under the curve (AUC) values greater than 0.7, indicating promising diagnostic value for these metabolites. Pathway analysis highlighted significant dysregulation in the metabolism of inositol phosphate, tyrosine, histidine, pyruvate, and the biosynthesis of phenylalanine, tryptophan, and tyrosine. This study provides a detailed overview of the metabolic disturbances associated with early-stage CKD and identifies potential biomarkers for early detection. These findings could contribute to the development of personalized therapeutic approaches for the early management of CKD. |
| Research Area: | Biological Sciences |
| Funding Source: | University Grants Commission |
| Project Contributors: | Upasna Gupta, Amrita Sahu, Dharmendra Singh Bhadauria, Bikash Baishya and Neeraj Sinha |
| Sr.No | Sample ID | Sample Name | Organism | Source | Sample Preparation Protocol | Sample Type | Experimental Condition | Time of treatment | Variant/Variety | Gender | Age | Replicates | Storage Conditions | Extraction Protocol | Number of files per sample |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IMSM_101327 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 2 | IMSM_101328 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 3 | IMSM_101329 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 4 | IMSM_101330 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 5 | IMSM_101331 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 6 | IMSM_101332 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 7 | IMSM_101333 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 8 | IMSM_101334 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 9 | IMSM_101335 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 10 | IMSM_101336 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 11 | IMSM_101337 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 12 | IMSM_101338 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 13 | IMSM_101339 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 14 | IMSM_101340 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 15 | IMSM_101341 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 16 | IMSM_101342 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 17 | IMSM_101343 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 18 | IMSM_101344 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 19 | IMSM_101345 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 20 | IMSM_101346 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 21 | IMSM_101347 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 22 | IMSM_101348 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 23 | IMSM_101349 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 24 | IMSM_101350 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 25 | IMSM_101351 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 26 | IMSM_101352 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 27 | IMSM_101353 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 28 | IMSM_101354 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 29 | IMSM_101355 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 30 | IMSM_101356 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 31 | IMSM_101357 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 32 | IMSM_101358 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 33 | IMSM_101359 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 34 | IMSM_101360 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 35 | IMSM_101361 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 36 | IMSM_101362 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 37 | IMSM_101363 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 38 | IMSM_101364 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 39 | IMSM_101365 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 40 | IMSM_101366 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 41 | IMSM_101367 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 42 | IMSM_101368 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 43 | IMSM_101369 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 44 | IMSM_101370 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 45 | IMSM_101371 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 46 | IMSM_101372 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 47 | IMSM_101373 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 48 | IMSM_101374 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 49 | IMSM_101375 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 50 | IMSM_101376 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 51 | IMSM_101377 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 52 | IMSM_101378 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 53 | IMSM_101379 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 54 | IMSM_101380 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 55 | IMSM_101381 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 56 | IMSM_101382 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 57 | IMSM_101383 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 58 | IMSM_101384 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 59 | IMSM_101385 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 60 | IMSM_101386 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 61 | IMSM_101387 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 62 | IMSM_101388 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 63 | IMSM_101389 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 64 | IMSM_101390 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 65 | IMSM_101391 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 66 | IMSM_101392 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 67 | IMSM_101393 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 68 | IMSM_101394 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 69 | IMSM_101395 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 70 | IMSM_101396 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 71 | IMSM_101397 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 72 | IMSM_101398 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 73 | IMSM_101399 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 74 | IMSM_101400 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 75 | IMSM_101401 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 76 | IMSM_101402 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 77 | IMSM_101403 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 78 | IMSM_101404 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 79 | IMSM_101405 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 80 | IMSM_101406 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 81 | IMSM_101407 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 82 | IMSM_101408 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 83 | IMSM_101409 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 84 | IMSM_101410 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 85 | IMSM_101411 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 86 | IMSM_101412 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 87 | IMSM_101413 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 88 | IMSM_101414 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 89 | IMSM_101415 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 90 | IMSM_101416 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 91 | IMSM_101417 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 92 | IMSM_101418 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 93 | IMSM_101419 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 94 | IMSM_101420 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 95 | IMSM_101421 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 96 | IMSM_101422 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 97 | IMSM_101423 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 98 | IMSM_101424 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 99 | IMSM_101425 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 100 | IMSM_101426 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 101 | IMSM_101427 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 102 | IMSM_101428 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 103 | IMSM_101429 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 104 | IMSM_101430 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 105 | IMSM_101431 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 106 | IMSM_101432 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 107 | IMSM_101433 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 108 | IMSM_101434 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 109 | IMSM_101435 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 110 | IMSM_101436 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 111 | IMSM_101437 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 112 | IMSM_101438 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 113 | IMSM_101439 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 114 | IMSM_101440 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 115 | IMSM_101441 | Human Blood | Homo sapiens | Blood | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
| Sr.No | NMR Exp ID | Sample Name/ID | Reference Standard | NMR Instrument Name | NMR Instrument Type | NMR Experiment Type | NMR Spectrometer Frequency | NMR Probe | NMR Probe temperature | NMR Solvent | NMR tube size | Data Transformation (Software/s Used) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IME_100572 | Human Blood / IMSM_101327 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 2 | IME_100573 | Human Blood / IMSM_101328 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 3 | IME_100574 | Human Blood / IMSM_101329 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 4 | IME_100575 | Human Blood / IMSM_101330 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 5 | IME_100576 | Human Blood / IMSM_101331 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 6 | IME_100577 | Human Blood / IMSM_101332 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 7 | IME_100578 | Human Blood / IMSM_101333 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 8 | IME_100579 | Human Blood / IMSM_101334 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 9 | IME_100580 | Human Blood / IMSM_101335 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 10 | IME_100581 | Human Blood / IMSM_101336 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 11 | IME_100582 | Human Blood / IMSM_101337 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 12 | IME_100583 | Human Blood / IMSM_101338 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 13 | IME_100584 | Human Blood / IMSM_101339 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 14 | IME_100585 | Human Blood / IMSM_101340 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 15 | IME_100586 | Human Blood / IMSM_101341 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 16 | IME_100587 | Human Blood / IMSM_101342 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 17 | IME_100588 | Human Blood / IMSM_101343 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 18 | IME_100589 | Human Blood / IMSM_101344 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 19 | IME_100590 | Human Blood / IMSM_101345 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 20 | IME_100591 | Human Blood / IMSM_101346 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 21 | IME_100592 | Human Blood / IMSM_101347 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 22 | IME_100593 | Human Blood / IMSM_101348 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 23 | IME_100594 | Human Blood / IMSM_101349 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 24 | IME_100595 | Human Blood / IMSM_101350 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 25 | IME_100596 | Human Blood / IMSM_101351 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 26 | IME_100597 | Human Blood / IMSM_101352 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 27 | IME_100598 | Human Blood / IMSM_101353 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 28 | IME_100599 | Human Blood / IMSM_101354 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 29 | IME_100600 | Human Blood / IMSM_101355 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 30 | IME_100601 | Human Blood / IMSM_101356 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 31 | IME_100602 | Human Blood / IMSM_101357 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 32 | IME_100603 | Human Blood / IMSM_101358 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 33 | IME_100604 | Human Blood / IMSM_101359 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 34 | IME_100605 | Human Blood / IMSM_101360 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 35 | IME_100606 | Human Blood / IMSM_101361 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 36 | IME_100607 | Human Blood / IMSM_101362 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 37 | IME_100608 | Human Blood / IMSM_101363 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 38 | IME_100609 | Human Blood / IMSM_101364 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 39 | IME_100610 | Human Blood / IMSM_101365 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 40 | IME_100611 | Human Blood / IMSM_101366 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 41 | IME_100612 | Human Blood / IMSM_101367 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 42 | IME_100613 | Human Blood / IMSM_101368 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 43 | IME_100614 | Human Blood / IMSM_101369 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 44 | IME_100615 | Human Blood / IMSM_101370 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 45 | IME_100616 | Human Blood / IMSM_101371 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 46 | IME_100617 | Human Blood / IMSM_101372 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 47 | IME_100618 | Human Blood / IMSM_101373 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 48 | IME_100619 | Human Blood / IMSM_101374 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 49 | IME_100620 | Human Blood / IMSM_101375 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 50 | IME_100621 | Human Blood / IMSM_101376 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 51 | IME_100622 | Human Blood / IMSM_101377 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 52 | IME_100623 | Human Blood / IMSM_101378 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 53 | IME_100624 | Human Blood / IMSM_101379 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 54 | IME_100625 | Human Blood / IMSM_101380 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 55 | IME_100626 | Human Blood / IMSM_101381 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 56 | IME_100627 | Human Blood / IMSM_101382 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 57 | IME_100628 | Human Blood / IMSM_101383 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 58 | IME_100629 | Human Blood / IMSM_101384 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 59 | IME_100630 | Human Blood / IMSM_101385 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 60 | IME_100631 | Human Blood / IMSM_101386 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 61 | IME_100632 | Human Blood / IMSM_101387 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 62 | IME_100633 | Human Blood / IMSM_101388 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 63 | IME_100634 | Human Blood / IMSM_101389 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 64 | IME_100635 | Human Blood / IMSM_101390 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 65 | IME_100636 | Human Blood / IMSM_101391 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 66 | IME_100637 | Human Blood / IMSM_101392 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 67 | IME_100638 | Human Blood / IMSM_101393 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 68 | IME_100639 | Human Blood / IMSM_101394 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 69 | IME_100640 | Human Blood / IMSM_101395 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 70 | IME_100641 | Human Blood / IMSM_101396 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 71 | IME_100642 | Human Blood / IMSM_101397 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 72 | IME_100643 | Human Blood / IMSM_101398 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 73 | IME_100644 | Human Blood / IMSM_101399 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 74 | IME_100645 | Human Blood / IMSM_101400 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 75 | IME_100646 | Human Blood / IMSM_101401 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 76 | IME_100647 | Human Blood / IMSM_101402 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 77 | IME_100648 | Human Blood / IMSM_101403 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 78 | IME_100649 | Human Blood / IMSM_101404 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 79 | IME_100650 | Human Blood / IMSM_101405 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 80 | IME_100651 | Human Blood / IMSM_101406 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 81 | IME_100652 | Human Blood / IMSM_101407 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 82 | IME_100653 | Human Blood / IMSM_101408 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 83 | IME_100654 | Human Blood / IMSM_101409 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 84 | IME_100655 | Human Blood / IMSM_101410 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 85 | IME_100656 | Human Blood / IMSM_101411 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 86 | IME_100657 | Human Blood / IMSM_101412 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 87 | IME_100658 | Human Blood / IMSM_101413 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 88 | IME_100659 | Human Blood / IMSM_101414 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 89 | IME_100660 | Human Blood / IMSM_101415 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 90 | IME_100661 | Human Blood / IMSM_101416 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 91 | IME_100662 | Human Blood / IMSM_101417 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 92 | IME_100663 | Human Blood / IMSM_101418 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 93 | IME_100664 | Human Blood / IMSM_101419 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 94 | IME_100665 | Human Blood / IMSM_101420 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 95 | IME_100666 | Human Blood / IMSM_101421 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 96 | IME_100667 | Human Blood / IMSM_101422 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 97 | IME_100668 | Human Blood / IMSM_101423 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 98 | IME_100669 | Human Blood / IMSM_101424 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 99 | IME_100670 | Human Blood / IMSM_101425 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 100 | IME_100671 | Human Blood / IMSM_101426 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 101 | IME_100672 | Human Blood / IMSM_101427 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 102 | IME_100673 | Human Blood / IMSM_101428 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 103 | IME_100674 | Human Blood / IMSM_101429 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 104 | IME_100675 | Human Blood / IMSM_101430 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 105 | IME_100676 | Human Blood / IMSM_101431 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 106 | IME_100677 | Human Blood / IMSM_101432 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 107 | IME_100678 | Human Blood / IMSM_101433 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 108 | IME_100679 | Human Blood / IMSM_101434 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 109 | IME_100680 | Human Blood / IMSM_101435 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 110 | IME_100681 | Human Blood / IMSM_101436 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 111 | IME_100682 | Human Blood / IMSM_101437 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 112 | IME_100683 | Human Blood / IMSM_101438 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 113 | IME_100684 | Human Blood / IMSM_101439 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 114 | IME_100685 | Human Blood / IMSM_101440 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 115 | IME_100686 | Human Blood / IMSM_101441 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| Sr.No | First name | Last name | Organization | Designation | |
|---|---|---|---|---|---|
| 1 | Neeraj | Sinha | neerajcbmr@gmail.com | Centre of Biomedical Research(CBMR), Lucknow | principal_investigator |
| 2 | Bikash | Baishya | bikash2baishya@gmail.com | Centre of Biomedical Research(CBMR), Lucknow | principal_investigator |
| 3 | Dharmendra Singh | Bhadauria | docdharm10@gmail.com | Centre of Biomedical Research(CBMR), Lucknow | principal_investigator |
| 4 | Amrita | Sahu | sahuamrita456@gmail.com | Centre of Biomedical Research(CBMR), Lucknow | research_scholar |
| 5 | Upasna | Gupta | upasnagupta941@gmail.com | Centre of Biomedical Research(CBMR), Lucknow | research_scholar |
| Sr.No | ftprun ID | NMR Exp ID | NMR Data Files |
|---|---|---|---|
| 1 | IMR_101171 | IME_100572 | 1.zip |
| 2 | IMR_101172 | IME_100573 | 3.zip |
| 3 | IMR_101173 | IME_100574 | 5.zip |
| 4 | IMR_101174 | IME_100575 | 7.zip |
| 5 | IMR_101175 | IME_100576 | 9.zip |
| 6 | IMR_101176 | IME_100577 | 11.zip |
| 7 | IMR_101177 | IME_100578 | 13.zip |
| 8 | IMR_101178 | IME_100579 | 18.zip |
| 9 | IMR_101179 | IME_100580 | 20.zip |
| 10 | IMR_101180 | IME_100581 | 22.zip |
| 11 | IMR_101181 | IME_100582 | 24.zip |
| 12 | IMR_101182 | IME_100583 | 26.zip |
| 13 | IMR_101183 | IME_100584 | 31.zip |
| 14 | IMR_101184 | IME_100585 | 33.zip |
| 15 | IMR_101185 | IME_100586 | 35.zip |
| 16 | IMR_101186 | IME_100587 | 36.zip |
| 17 | IMR_101187 | IME_100588 | 37.zip |
| 18 | IMR_101188 | IME_100589 | 39.zip |
| 19 | IMR_101189 | IME_100590 | 40.zip |
| 20 | IMR_101190 | IME_100591 | 41.zip |
| 21 | IMR_101191 | IME_100592 | 42.zip |
| 22 | IMR_101192 | IME_100593 | 43.zip |
| 23 | IMR_101193 | IME_100594 | 44.zip |
| 24 | IMR_101194 | IME_100595 | 46.zip |
| 25 | IMR_101195 | IME_100596 | 213.zip |
| 26 | IMR_101196 | IME_100597 | 217.zip |
| 27 | IMR_101197 | IME_100598 | 219.zip |
| 28 | IMR_101198 | IME_100599 | 221.zip |
| 29 | IMR_101199 | IME_100600 | 223.zip |
| 30 | IMR_101200 | IME_100601 | 225.zip |
| 31 | IMR_101201 | IME_100602 | 227.zip |
| 32 | IMR_101202 | IME_100603 | 229.zip |
| 33 | IMR_101203 | IME_100604 | 231.zip |
| 34 | IMR_101204 | IME_100605 | 233.zip |
| 35 | IMR_101205 | IME_100606 | 235.zip |
| 36 | IMR_101206 | IME_100607 | 237.zip |
| 37 | IMR_101207 | IME_100608 | 239.zip |
| 38 | IMR_101208 | IME_100609 | 241.zip |
| 39 | IMR_101209 | IME_100610 | 243.zip |
| 40 | IMR_101210 | IME_100611 | 245.zip |
| 41 | IMR_101211 | IME_100612 | 247.zip |
| 42 | IMR_101212 | IME_100613 | 249.zip |
| 43 | IMR_101213 | IME_100614 | 251.zip |
| 44 | IMR_101214 | IME_100615 | 253.zip |
| 45 | IMR_101215 | IME_100616 | 255.zip |
| 46 | IMR_101216 | IME_100617 | 257.zip |
| 47 | IMR_101217 | IME_100618 | 259.zip |
| 48 | IMR_101218 | IME_100619 | 261.zip |
| 49 | IMR_101219 | IME_100620 | 263.zip |
| 50 | IMR_101220 | IME_100621 | 265.zip |
| 51 | IMR_101221 | IME_100622 | 267.zip |
| 52 | IMR_101222 | IME_100623 | 269.zip |
| 53 | IMR_101223 | IME_100624 | 271.zip |
| 54 | IMR_101224 | IME_100625 | 273.zip |
| 55 | IMR_101225 | IME_100626 | 275.zip |
| 56 | IMR_101226 | IME_100627 | 277.zip |
| 57 | IMR_101227 | IME_100628 | 279.zip |
| 58 | IMR_101228 | IME_100629 | 281.zip |
| 59 | IMR_101229 | IME_100630 | 283.zip |
| 60 | IMR_101230 | IME_100631 | 285.zip |
| 61 | IMR_101231 | IME_100632 | 287.zip |
| 62 | IMR_101232 | IME_100633 | 289.zip |
| 63 | IMR_101233 | IME_100634 | 291.zip |
| 64 | IMR_101234 | IME_100635 | 293.zip |
| 65 | IMR_101235 | IME_100636 | 295.zip |
| 66 | IMR_101236 | IME_100637 | 297.zip |
| 67 | IMR_101237 | IME_100638 | 299.zip |
| 68 | IMR_101238 | IME_100639 | 301.zip |
| 69 | IMR_101239 | IME_100640 | 303.zip |
| 70 | IMR_101240 | IME_100641 | 305.zip |
| 71 | IMR_101241 | IME_100642 | 307.zip |
| 72 | IMR_101242 | IME_100643 | 309.zip |
| 73 | IMR_101243 | IME_100644 | 311.zip |
| 74 | IMR_101244 | IME_100645 | 328.zip |
| 75 | IMR_101245 | IME_100646 | 330.zip |
| 76 | IMR_101246 | IME_100647 | 332.zip |
| 77 | IMR_101247 | IME_100648 | 334.zip |
| 78 | IMR_101248 | IME_100649 | 336.zip |
| 79 | IMR_101249 | IME_100650 | 338.zip |
| 80 | IMR_101250 | IME_100651 | 340.zip |
| 81 | IMR_101251 | IME_100652 | 342.zip |
| 82 | IMR_101252 | IME_100653 | 344.zip |
| 83 | IMR_101253 | IME_100654 | 346.zip |
| 84 | IMR_101254 | IME_100655 | 348.zip |
| 85 | IMR_101255 | IME_100656 | 350.zip |
| 86 | IMR_101256 | IME_100657 | 382.zip |
| 87 | IMR_101257 | IME_100658 | 384.zip |
| 88 | IMR_101258 | IME_100659 | 386.zip |
| 89 | IMR_101259 | IME_100660 | 388.zip |
| 90 | IMR_101260 | IME_100661 | 390.zip |
| 91 | IMR_101261 | IME_100662 | 392.zip |
| 92 | IMR_101262 | IME_100663 | 394.zip |
| 93 | IMR_101263 | IME_100664 | 401.zip |
| 94 | IMR_101264 | IME_100665 | 420.zip |
| 95 | IMR_101265 | IME_100666 | 421.zip |
| 96 | IMR_101266 | IME_100667 | 422.zip |
| 97 | IMR_101267 | IME_100668 | 423.zip |
| 98 | IMR_101268 | IME_100669 | 424.zip |
| 99 | IMR_101269 | IME_100670 | 425.zip |
| 100 | IMR_101270 | IME_100671 | 427.zip |
| 101 | IMR_101271 | IME_100672 | 428.zip |
| 102 | IMR_101272 | IME_100673 | 429.zip |
| 103 | IMR_101273 | IME_100674 | 434.zip |
| 104 | IMR_101274 | IME_100675 | 435.zip |
| 105 | IMR_101275 | IME_100676 | 436.zip |
| 106 | IMR_101276 | IME_100677 | 437.zip |
| 107 | IMR_101277 | IME_100678 | 438.zip |
| 108 | IMR_101278 | IME_100679 | 439.zip |
| 109 | IMR_101279 | IME_100680 | 440.zip |
| 110 | IMR_101280 | IME_100681 | 445.zip |
| 111 | IMR_101281 | IME_100682 | 446.zip |
| 112 | IMR_101282 | IME_100683 | 447.zip |
| 113 | IMR_101283 | IME_100684 | 448.zip |
| 114 | IMR_101284 | IME_100685 | 449.zip |
| 115 | IMR_101285 | IME_100686 | 450.zip |
Download Metabolite/Compound
| Sr.No | Structure | Details |
|---|